Moderna: Stock to Avoid or Bad News Buy?
The Motley Fool
by newsfeedback@fool.com (Adria Cimino)February 12, 2026
Moderna stock was a highflier in early pandemic days as sales of its coronavirus vaccine soared.
Verticals
financeinvesting
Originally published on The Motley Fool on 2/12/2026